Market Tracker

07/01 5:16pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

25.99
Delayed Data
As of 4:00pm ET
 +0.485 / +1.90%
Today’s Change
23.85
Today|||52-Week Range
43.63
-39.25%
Year-to-Date

Today’s Trading

Previous close25.51
Today’s open25.56
Day’s range25.19 - 26.24
Volume488,491
Average volume (3 months)728,713
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-40.48%
Earnings growth (this year)-28.85%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+22.71%
P/E ratio84.5
Price/Sales3.79
Price/Book1.82

Competitors

 Today’s
change
Today’s
% change
INVAInnoviva Inc+0.53+5.03%
PRTAProthena Corporation...+3.49+9.98%
EBSEmergent BioSolution...+0.59+2.10%
ALDRAlder Biopharmaceuti...+0.98+3.92%
Data as of 4:02pm ET, 07/01/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.20
Annual revenue (last year)$492.7M
Annual profit (last year)$11.1M
Net profit margin2.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Head-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts